ES2133052A1 - Nuevas formulaciones farmaceuticas liquidas para la via oral. - Google Patents

Nuevas formulaciones farmaceuticas liquidas para la via oral.

Info

Publication number
ES2133052A1
ES2133052A1 ES09600972A ES9600972A ES2133052A1 ES 2133052 A1 ES2133052 A1 ES 2133052A1 ES 09600972 A ES09600972 A ES 09600972A ES 9600972 A ES9600972 A ES 9600972A ES 2133052 A1 ES2133052 A1 ES 2133052A1
Authority
ES
Spain
Prior art keywords
oral administration
pharmaceutical formulations
liquid pharmaceutical
new liquid
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09600972A
Other languages
English (en)
Other versions
ES2133052B1 (es
Inventor
Vidal Jose Luis Fabregas
Carbonell Antoni Masso
Mauri Jacinto Moragues
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Almirall Prodesfarma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma SA filed Critical Almirall Prodesfarma SA
Priority to ES9600972A priority Critical patent/ES2133052B1/es
Publication of ES2133052A1 publication Critical patent/ES2133052A1/es
Application granted granted Critical
Publication of ES2133052B1 publication Critical patent/ES2133052B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Nuevas formulaciones farmacéuticas liquidas para la vía oral que comprenden un antagonista del calcio de estructura dihidropiridina y uno o varios tensioactivos no iónicos con un balance hidrofílico-lipofílico superior a 12, uno o varios covalentes orgánicos mono o polihidroxilados y, opcionalmente, uno o varios disolventes di o triglicéridos de cadena media y con un tamaño micelar reducido. Las nuevas composiciones terapéuticas del invento son útiles en el tratamiento de enfermedades coronarias, profilaxis del angor, promoción de la vasodilatación cerebral, y tratamiento de la hipertensión.
ES9600972A 1996-04-29 1996-04-29 Nuevas formulaciones farmaceuticas liquidas para la via oral. Expired - Fee Related ES2133052B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9600972A ES2133052B1 (es) 1996-04-29 1996-04-29 Nuevas formulaciones farmaceuticas liquidas para la via oral.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9600972A ES2133052B1 (es) 1996-04-29 1996-04-29 Nuevas formulaciones farmaceuticas liquidas para la via oral.

Publications (2)

Publication Number Publication Date
ES2133052A1 true ES2133052A1 (es) 1999-08-16
ES2133052B1 ES2133052B1 (es) 2000-05-01

Family

ID=8294660

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9600972A Expired - Fee Related ES2133052B1 (es) 1996-04-29 1996-04-29 Nuevas formulaciones farmaceuticas liquidas para la via oral.

Country Status (1)

Country Link
ES (1) ES2133052B1 (es)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57167911A (en) * 1981-04-09 1982-10-16 Kyoto Yakuhin Kogyo Kk Liquid pharmaceutical of nifedipine
ES8503948A1 (es) * 1983-03-03 1985-04-16 Bayer Ag Un procedimiento para la fabricacion de nueva preparacion liquida de dihidropiridinas de rapida absorcion del producto activo y gran estabilidad.
WO1995008987A1 (en) * 1993-09-28 1995-04-06 Krka Tovarna Zdravil, P.O. Process for preparation of solid disperions and deposits as well as of solid medicinal forms with dihydropyridine type calcium antagonists

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57167911A (en) * 1981-04-09 1982-10-16 Kyoto Yakuhin Kogyo Kk Liquid pharmaceutical of nifedipine
ES8503948A1 (es) * 1983-03-03 1985-04-16 Bayer Ag Un procedimiento para la fabricacion de nueva preparacion liquida de dihidropiridinas de rapida absorcion del producto activo y gran estabilidad.
WO1995008987A1 (en) * 1993-09-28 1995-04-06 Krka Tovarna Zdravil, P.O. Process for preparation of solid disperions and deposits as well as of solid medicinal forms with dihydropyridine type calcium antagonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BASE DE DATOS CAS. QUESTEL. AN 098-059913. Oral liquid formulations containing nifedipine & JP 57167911 A (KYOTO PHARMACEUTICAL INDUSTRIES) 16.10.1982 *

Also Published As

Publication number Publication date
ES2133052B1 (es) 2000-05-01

Similar Documents

Publication Publication Date Title
TWI265808B (en) Valdecoxib compositions
AP1637A (en) Celecoxib compositions.
CO5251419A1 (es) Composiciones nanoparticuladas de eplerenona
MY118371A (en) Tetrahydrolipstatin containing compositions
FR2727016B1 (fr) Compositions pharmaceutiques a base d'ondansetron
HUP0302319A2 (hu) Gyógyszerkészítmények gyógyászati hatóanyagok szájon át történő bejuttatására
FR2808685B1 (fr) Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires
BG104620A (en) Oral pharmaceutical extended release dosage form
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
SV2002000235A (es) Composiciones farmaceuticas que comprenden valdecoxib
HUP0104410A2 (hu) Ateroszklerózis megelőzésére és/vagy kezelésére szolgáló gyógyszerkészítmények
DE3669106D1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
DE69919533D1 (de) Proteinhaltige arzneimittel
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
HUP0203721A2 (hu) Új hormonkészítmény és alkalmazása
CA2135179A1 (en) Pharmaceutical Compositions of Alkylsulphonamides 5HT1 Agonists for Rectal Administration
ES2133052A1 (es) Nuevas formulaciones farmaceuticas liquidas para la via oral.
DE60031385D1 (de) Pharmazeutische Zusammensetzungen von Antibiotika und Fruktan-Gemische
HUP0100634A2 (hu) Pentaeritrit-tetranitrátot tartalmazó gyógyászati készítmények
DE69814669T2 (de) Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten
TNSN00242A1 (en) VALDECOXIB COMPOSITIONS
ECSP982396A (es) Composiciones que contienen tetrahidrolipstatina
AR033424A1 (es) Composiciones farmaceuticas
CA2205600A1 (en) Freeze-dried ondansetron compositions

Legal Events

Date Code Title Description
PC2A Transfer of patent
PC2A Transfer of patent
EC2A Search report published

Date of ref document: 19990816

Kind code of ref document: A1

Effective date: 19990816

FD2A Announcement of lapse in spain

Effective date: 20180807